HA

Hansaben Ashwingiri Gosai

Active Director Director DIN 10264613
DIN 10264613 First appointment Aug 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Hansaben Ashwingiri Gosai

Data last updated:

Hansaben Ashwingiri Gosai is a Director at Neosurgix Medical Technologies Private Limited (since 2023). Neosurgix Medical Technologies Private Limited reported revenue of ₹61,012 (FY 2025).

DIN 10264613
Primary Designation Director
First Appointment 02 Aug 2023
Oldest Company Age 3 yrs
Largest company Neosurgix Medical Technologies Private Limited · ₹61,012 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Aug 20232023₹61,012 (FY 2025)Active

Board colleagues of Hansaben Ashwingiri Gosai

Directorship timeline

Open interactive timeline →
Neosurgix Medical Technologies Private Limited
Premium access

Shareholding and investment profile for Hansaben Ashwingiri Gosai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hansaben Ashwingiri Gosai

Hansaben Ashwingiri Gosai currently holds 1 directorship: Neosurgix Medical Technologies Private Limited (Director, since 02 Aug 2023, revenue ₹61,012 (FY 2025)).

Hansaben Ashwingiri Gosai was first appointed on 02 Aug 2023 as Director at Neosurgix Medical Technologies Private Limited.

The current boards of Hansaben Ashwingiri Gosai's companies include Gaurangkumar Ashwingiri Gosai (Neosurgix Medical Technologies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available